Literature DB >> 7141690

Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.

S J Cryz, E Fürer, R Germanier.   

Abstract

The effects of heat and chemical inactivation on the antigenicity and immunogenicity of Vibrio cholerae 1418 in rabbits were studied. V. cholerae 1418 was inactivated with heat and chemical inactivants (phenol or Formalin) alone or in combination. Enzyme-linked immunoassay systems employing whole cells of V. cholerae 1418, lipopolysaccharide, or flagella as immobilized antigens were used to measure the antibody response (immunoglobulins G and M) after parenteral immunization of rabbits with various inactivated whole-cell preparations. The "classical" whole-cell vaccine, produced by phenol treatment, was found to be a comparatively poor immunogen. When Formalin was used instead of phenol, the antibody response to all three enzyme-linked immunosorbent assay antigens was greatly increased. Immunoglobulin G titers to intact V. cholerae cells were as much as 100-fold higher in rabbits immunized with the Formalin-inactivated preparation as compared to the classical phenol-inactivated vaccine. Furthermore, antibody produced against the Formalin-inactivated preparation was capable of recognizing antigenic determinants expressed on the cell surface of several heterologous strains of V. cholerae. These results indicate that the antigenicity and immunogenicity of V. cholerae are greatly affected by the inactivation conditions employed for vaccine production and that Formalin is much superior to phenol as an inactivant under the conditions employed in the present study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141690      PMCID: PMC347690          DOI: 10.1128/iai.38.1.21-26.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.

Authors:  W H Mosley; W E Woodward; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed; J C Feeley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

3.  Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation.

Authors:  W H Mosley; W M McCormack; M Fahimuddin; K M Aziz; A S Rahman; A K Chowdhury; A R Martin; J C Feeley; R A Phillips
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.

Authors:  J C Azurin; A Cruz; T P Pesigan; M Alvero; T Camena; R Suplido; L Ledesma; C Z Gomez
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

5.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

6.  Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.

Authors:  R S Rappaport; G Bonde; T McCann; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

7.  Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

8.  Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.

Authors:  N F Pierce; W C Cray; P F Engel
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.

Authors:  W H Mosley; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

View more
  17 in total

1.  Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

Authors:  Fei Wang; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Soracha Thamphiwatana; Diana Dehaini; Pavimol Angsantikul; Ashley V Kroll; Zhiqing Pang; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal:  Adv Funct Mater       Date:  2016-02-05       Impact factor: 18.808

Review 2.  Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.

Authors:  Peter Y Li; Zhiyuan Fan; Hao Cheng
Journal:  Bioconjug Chem       Date:  2018-01-11       Impact factor: 4.774

Review 3.  Engineered nanoparticles mimicking cell membranes for toxin neutralization.

Authors:  Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2015-04-11       Impact factor: 15.470

4.  In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.

Authors:  Xiaoli Wei; Jie Gao; Fei Wang; Man Ying; Pavimol Angsantikul; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Weiyue Lu; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2017-06-28       Impact factor: 30.849

Review 5.  Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.

Authors:  Svetlana T Yurkin; Zhenjia Wang
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

Review 6.  Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.

Authors:  Pavimol Angsantikul; Ronnie H Fang; Liangfang Zhang
Journal:  Bioconjug Chem       Date:  2017-12-27       Impact factor: 4.774

7.  Monoclonal antibody-based enzyme-linked immunosorbent assays for identification and serotyping of Vibrio cholerae O1.

Authors:  B Gustafsson
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

Review 8.  Bacteria-Inspired Nanomedicine.

Authors:  Maya Holay; Zhongyuan Guo; Jessica Pihl; Jiyoung Heo; Joon Ho Park; Ronnie H Fang; Liangfang Zhang
Journal:  ACS Appl Bio Mater       Date:  2020-10-08

9.  The Effect of Solar Irradiated Vibrio cholerae on the Secretion of Pro-Inflammatory Cytokines and Chemokines by the JAWS II Dendritic Cell Line In Vitro.

Authors:  Cornelius Cano Ssemakalu; Eunice Ubomba-Jaswa; Keolebogile Shirley Motaung; Michael Pillay
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

10.  Nanoparticle-detained toxins for safe and effective vaccination.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Liangfang Zhang
Journal:  Nat Nanotechnol       Date:  2013-12-01       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.